{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T02:03:43Z","timestamp":1779847423662,"version":"3.53.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"DOI":"10.1186\/s13019-026-03971-8","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T08:28:07Z","timestamp":1775896087000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correlation between Cx37 and ALK expression and prognosis of elderly patients with non-small cell lung cancer"],"prefix":"10.1186","volume":"21","author":[{"given":"Yansheng","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"key":"3971_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"3971_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jtho.2020.10.006","volume":"16","author":"X Le","year":"2021","unstructured":"Le X, Nilsson M, Goldman J, et al. Dual EGF\u0f32-VEGF pathway inhibition: a promising strategy for patients with EGFR-mutant NSCLC. J Thorac Oncol. 2021;16(2):205\u201315.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"3971_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jmoldx.2010.11.010","volume":"13","author":"Z Su","year":"2011","unstructured":"Su Z, Dias-Santagata D, Duke M, et al. A platform for rapid detection of multiple oncogenic mutations with relevance to targeted therapy in non-small-cell lung cancer. J Mol Diagn. 2011;13(1):74\u201384.","journal-title":"J Mol Diagn"},{"issue":"4","key":"3971_CR4","doi-asserted-by":"publisher","first-page":"871","DOI":"10.2214\/AJR.21.25618","volume":"217","author":"J Choe","year":"2021","unstructured":"Choe J, Kim MY, Yun JK, et al. Sublobar resection in stage ia non-small cell lung cancer: role of preoperative ct features in predicting pathologic lymphovascular invasion and postoperative recurrence. AJR Am J Roentgenol. 2021;217(4):871\u201381.","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"3971_CR5","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1016\/S2214-109X(18)30488-1","volume":"7","author":"W Chen","year":"2019","unstructured":"Chen W, Xia C, Zheng R, et al. Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment. Lancet Glob Health. 2019;7(2):e257-269.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"3971_CR6","first-page":"66","volume":"41","author":"C Zhang","year":"2021","unstructured":"Zhang C, Pan D, Yu X. Effects of Yifei-Xiaoai decoction combined with chemotherapy on VEGF, MMP-2 and MMP-9 in patients with advanced non-small cell lung cancer. Jilin Tradit Chin Med. 2021;41(1):66\u20139.","journal-title":"Jilin Tradit Chin Med"},{"issue":"12","key":"3971_CR7","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S1470-2045(19)30519-4","volume":"20","author":"R Hui","year":"2019","unstructured":"Hui R, Ozg\u00fcro\u02c7glu M, Villegas A. Patient-reported outcomes with durvalumab after chemoradiotherapy in stage \u2162, unresectable nonsmall-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study. Lancet Oncol. 2019;20(12):1670\u201380.","journal-title":"Lancet Oncol"},{"issue":"7689","key":"3971_CR8","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446\u201354.","journal-title":"Nature"},{"issue":"23","key":"3971_CR9","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1038\/s41388-019-0741-6","volume":"38","author":"T Aasen","year":"2019","unstructured":"Aasen T, Leithe E, Graham SV, et al. Connexins in cancer: bridging the gap to the clinic. Oncogene. 2019;38(23):4429\u201351.","journal-title":"Oncogene"},{"issue":"3","key":"3971_CR10","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/CAD.0000000000000716","volume":"30","author":"M Zhang","year":"2019","unstructured":"Zhang M, Qiu SF. Activation of GPR120 promotes the metastasis of breast cancer through the PI3K\/Akt \/NF-\u03baB signaling pathway. Anticancer Drugs. 2019;30(3):260\u201370.","journal-title":"Anticancer Drugs"},{"issue":"7","key":"3971_CR11","doi-asserted-by":"publisher","first-page":"807","DOI":"10.6004\/jnccn.2018.0062","volume":"16","author":"D Ettinger","year":"2018","unstructured":"Ettinger D, Aisner D, Wood D, et al. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5. 2018. J Natl Compr Canc Netw. 2018;16(7):807\u201321.","journal-title":"J Natl Compr Canc Netw"},{"issue":"7","key":"3971_CR12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.21037\/qims.2018.08.02","volume":"8","author":"W Lim","year":"2018","unstructured":"Lim W, Ridge C, Nicholson A, et al. The 8th lung cancer TNM classification and clinical staging system: review of the changes and clinical implications. Quant Imaging Med Surg. 2018;8(7):709\u201318.","journal-title":"Quant Imaging Med Surg"},{"key":"3971_CR13","unstructured":"World Health Organization. Active ageing: a policy framework. World Health Organization. Published online April 1, 2002. Accessed January 5. 2026. https:\/\/apps.who.int\/iris\/handle\/10665\/67215"},{"issue":"3","key":"3971_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jncc.2024.05.002","volume":"4","author":"L Li","year":"2024","unstructured":"Li L, Shan T, Zhang D, Ma F. Nowcasting and forecasting global aging and cancer burden: analysis of data from the GLOBOCAN and Global Burden of Disease Study. J Natl Cancer Cent. 2024;4(3):223\u201332. https:\/\/doi.org\/10.1016\/j.jncc.2024.05.002. Published 2024 May 9.","journal-title":"J Natl Cancer Cent"},{"issue":"11","key":"3971_CR15","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/j.jtho.2021.07.009","volume":"16","author":"M Socinski","year":"2021","unstructured":"Socinski M, Nishio M, Jotte R, et al. IMpower150 Final Overall Survival Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC. J Thorac Oncol. 2021;16(11):1909\u201324.","journal-title":"J Thorac Oncol"},{"issue":"4","key":"3971_CR16","first-page":"277","volume":"51","author":"Chinese Anti-Cancer Association, Committee of Tumor Pathology; Chinese Society of Pathology","year":"2022","unstructured":"Chinese Anti-Cancer Association, Committee of Tumor Pathology; Chinese Society of Pathology. Chinese expert consensus on the clinical practice of ALK detection in non-small cell lung cancer. Zhonghua Bing Li Xue Za Zhi [Chin J Pathol]. 2022;51(4):277\u201387.","journal-title":"Zhonghua Bing Li Xue Za Zhi [Chin J Pathol]"},{"issue":"7","key":"3971_CR17","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.3390\/cells10071632","volume":"10","author":"A Rugamba","year":"2021","unstructured":"Rugamba A, Kang D, Sp N, et al. Silibinin regulates tumor progression and Tumorsphere Formation by suppressing PD-L1 expression in non-small cell lung cancer (NSCLC) cells. Cells. 2021;10(7):1632.","journal-title":"Cells"},{"issue":"1","key":"3971_CR18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41416-021-01606-4","volume":"126","author":"AM Hopkins","year":"2022","unstructured":"Hopkins AM, Kichenadasse G, McKinnon RA, et al. Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of impower150. Br J Cancer. 2022;126(1):42\u20137.","journal-title":"Br J Cancer"},{"issue":"5","key":"3971_CR19","first-page":"763","volume":"46","author":"F Qiu","year":"2022","unstructured":"Qiu F, Yu G, Zhang Q, et al. To study the effect of sequence of chemotherapy and targeted therapy on the progression and survival of patients with advanced advanced non-small cell lung cancer. Guizhou Med. 2022;46(5):763\u20134.","journal-title":"Guizhou Med"},{"issue":"5","key":"3971_CR20","first-page":"207","volume":"38","author":"Z Qiao","year":"2020","unstructured":"Qiao Z, Yang L, WANG X, et al. Intensity-modulated radiotherapy combined with Kanglaite injection combined with TP chemotherapy was selected Advanced non-small cell lung cancer clinical curative effect, immune function and the influence of adverse reaction. Chin J traditional Chin Med. 2020;38(5):207\u201311.","journal-title":"Chin J traditional Chin Med"},{"issue":"5","key":"3971_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26052120","volume":"26","author":"A Baladi","year":"2025","unstructured":"Baladi A, Tafenzi HA, Zouiten O, et al. Immunotherapy for elderly patients with advanced non-small cell lung cancer: challenges and perspectives. Int J Mol Sci. 2025;26(5):2120. https:\/\/doi.org\/10.3390\/ijms26052120.","journal-title":"Int J Mol Sci"},{"key":"3971_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33583","author":"L Cai","year":"2021","unstructured":"Cai L, Chen Y, Tong X, et al. The genomic landscape of young and old lung cancer patients highlights age-dependent mutation frequencies and clinical actionability in young patients. Int J Cancer. 2021. https:\/\/doi.org\/10.1002\/ijc.33583.","journal-title":"Int J Cancer"},{"key":"3971_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.806845","volume":"11","author":"M Hu","year":"2022","unstructured":"Hu M, Tan J, Liu Z, et al. Comprehensive comparative molecular characterization of Young and Old lung cancer patients. Front Oncol. 2022;11:806845. https:\/\/doi.org\/10.3389\/fonc.2021.806845.","journal-title":"Front Oncol"},{"issue":"6","key":"3971_CR24","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/s41416-020-0986-4","volume":"123","author":"F Gomes","year":"2020","unstructured":"Gomes F, Wong M, Battisti NML, et al. Immunotherapy in older patients with non-small cell lung cancer: Young International Society of Geriatric Oncology position paper. Br J Cancer. 2020;123(6):874\u201384. https:\/\/doi.org\/10.1038\/s41416-020-0986-4.","journal-title":"Br J Cancer"},{"issue":"3","key":"3971_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030769","volume":"14","author":"L Greillier","year":"2022","unstructured":"Greillier L, Gauvrit M, Paillaud E, et al. Targeted therapy for older patients with non-small cell lung cancer: systematic review and guidelines from the French Society of Geriatric Oncology (SoFOG) and the French-Language Society of Pulmonology (SPLF)\/French-Language Oncology Group (GOLF). Cancers (Basel). 2022;14(3):769. https:\/\/doi.org\/10.3390\/cancers14030769.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"3971_CR26","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1158\/1078-0432.CCR-09-2845","volume":"6","author":"K Mino","year":"2010","unstructured":"Mino K, Chirieac L, Law K, et al. A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry. Clin Cancer Res. 2010;6(5):1561\u2013171.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3971_CR27","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1186\/s12885-021-08824-2","volume":"21","author":"X Yang","year":"2021","unstructured":"Yang X, Zhong J, Yu Z, et al. Genetic and treatment profiles of patients with concurrent Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) mutations. BMC Cancer. 2021;21(1):1107.","journal-title":"BMC Cancer"},{"issue":"15","key":"3971_CR28","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1158\/1078-0432.CCR-13-0318","volume":"19","author":"J Gainor","year":"2013","unstructured":"Gainor J, Varghese A, et al. ALK rearrangements are mutually exclusive with mutations in EGFR or KRAS: an analysis of 1 683 patients with non-small cell lung cancer. Clin Cancer Res. 2013;19(15):4273\u201381.","journal-title":"Clin Cancer Res"},{"issue":"7689","key":"3971_CR29","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"R Herbst","year":"2018","unstructured":"Herbst R, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446\u201354.","journal-title":"Nature"},{"key":"3971_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00237","volume":"5","author":"K Schalper","year":"2014","unstructured":"Schalper K, Carvajal-Hausdorf D, Oyarzo M. Possible role of hemichannels in cancer. Front Physiol. 2014;5:237.","journal-title":"Front Physiol"},{"issue":"4","key":"3971_CR31","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.bbadis.2013.01.001","volume":"1832","author":"J Talbot","year":"2013","unstructured":"Talbot J, Brion R, Picarda G, et al. Loss of connexin43 expression in Ewing s sarcoma cells favors the development of the primary tumor and the associated bone osteolysis. Biochim Biophys Acta. 2013;1832(4):553\u201364.","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"3971_CR32","first-page":"3080","volume":"7","author":"K Yang","year":"2014","unstructured":"Yang K, Xu W, Liu Y, et al. Study on the effect of BMSCs-EGFP-tk as mediator of HSV1-tk \/GCV suicide gene therapydirected against A549 in vitro. Int J Clin Exp Med. 2014;7(9):3080\u20136.","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"3971_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19010295","volume":"19","author":"S Carballo","year":"2018","unstructured":"Carballo S, Pfenniger A, Carballo D, et al. Differential association of Cx37 and Cx40 genetic variants in atrial fibrillation with and without underlying structural heart disease. Int J Mol Sci. 2018;19(1):295.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"3971_CR34","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.7314\/APJCP.2012.13.5.2363","volume":"13","author":"Y Jing","year":"2012","unstructured":"Jing Y, Guo S, Zhang X, et al. Association between C1019T polymorphism in the connexin 37 gene and Helicobacter pylori infection in patients with gastric cancer. Asian Pac J Cancer Prev. 2012;13(5):2363\u20137.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"25","key":"3971_CR35","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1214886","volume":"368","author":"AT Shaw","year":"2013","unstructured":"Shaw AT, Kim DW, Nakagawa K, et al. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. N Engl J Med. 2013;368(25):2385\u201394. https:\/\/doi.org\/10.1056\/NEJMoa1214886.","journal-title":"N Engl J Med"},{"issue":"16","key":"3971_CR36","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1056\/NEJMx150034","volume":"373","author":"First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer","year":"2015","unstructured":"First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer. N Engl J Med. 2015;373(16):1582. https:\/\/doi.org\/10.1056\/NEJMx150034.","journal-title":"N Engl J Med"},{"issue":"12","key":"3971_CR37","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/nrc.2016.105","volume":"42","author":"T Aasen","year":"2016","unstructured":"Aasen T, Mesnil M, Naus CC, Lampe PD, Laird DW. Gap junctions and cancer: communicating for 50 years. Nat Rev Cancer. 2016;42(12):775\u201388. https:\/\/doi.org\/10.1038\/nrc.2016.105.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"3971_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13081940","volume":"13","author":"R Rami-Porta","year":"2021","unstructured":"Rami-Porta R. Future perspectives on the TNM staging for lung cancer. Cancers (Basel). 2021;13(8):1940. https:\/\/doi.org\/10.3390\/cancers13081940.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"3971_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14061400","volume":"14","author":"S Garinet","year":"2022","unstructured":"Garinet S, Wang P, Mansuet-Lupo A, Fournel L, Wislez M, Blons H. Updated prognostic factors in localized NSCLC. Cancers (Basel). 2022;14(6):1400. https:\/\/doi.org\/10.3390\/cancers14061400.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"3971_CR40","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/1759-7714.14218","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang Y, Zhang T, Zhou Z, et al. Development and validation of a prediction model using molecular marker for long-term survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy. Thorac Cancer. 2022;13(3):296\u2013307. https:\/\/doi.org\/10.1111\/1759-7714.14218.","journal-title":"Thorac Cancer"},{"issue":"7","key":"3971_CR41","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.jtho.2019.03.015","volume":"14","author":"JR Kratz","year":"2019","unstructured":"Kratz JR, Haro GJ, Cook NR, et al. Incorporation of a molecular prognostic classifier improves conventional non-small cell lung cancer staging. J Thorac Oncol. 2019;14(7):1223\u201332. https:\/\/doi.org\/10.1016\/j.jtho.2019.03.015.","journal-title":"J Thorac Oncol"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-026-03971-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-03971-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-03971-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T01:27:46Z","timestamp":1779845266000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13019-026-03971-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3971"],"URL":"https:\/\/doi.org\/10.1186\/s13019-026-03971-8","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The subjects and their families signed an informed consent form, and the study was approved by the Medical Ethics Committee of Guizhou Provincial People\u2019s Hospital. All methods were carried out in accordance with Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"262"}}